387 related articles for article (PubMed ID: 37985986)
21. Soft drink consumption linked with fatty liver in the absence of traditional risk factors.
Assy N; Nasser G; Kamayse I; Nseir W; Beniashvili Z; Djibre A; Grosovski M
Can J Gastroenterol; 2008 Oct; 22(10):811-6. PubMed ID: 18925303
[TBL] [Abstract][Full Text] [Related]
22. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.
Zahoor F; Saeed NU; Javed S; Sadiq HZ; Mand Khan F; Haider M; Shafqat MN; Maqbool A; Chaudhry A
Cureus; 2023 Oct; 15(10):e47240. PubMed ID: 38021965
[TBL] [Abstract][Full Text] [Related]
23. Soft drink consumption is associated with increased incidence of the metabolic syndrome only in women.
Kang Y; Kim J
Br J Nutr; 2017 Jan; 117(2):315-324. PubMed ID: 28166856
[TBL] [Abstract][Full Text] [Related]
24. Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.
Kim D; Manikat R; Wijarnpreecha K; Cholankeril G; Ahmed A
J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38740513
[TBL] [Abstract][Full Text] [Related]
25. Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men.
Crudele L; De Matteis C; Novielli F; Di Buduo E; Petruzzelli S; De Giorgi A; Antonica G; Berardi E; Moschetta A
Biol Sex Differ; 2024 May; 15(1):43. PubMed ID: 38760802
[TBL] [Abstract][Full Text] [Related]
26. Association between Soft Drink Consumption and Asthma among Qatari Adults.
Ibrahim AA; Qamar B; Fituri S; Akbar ZA; Al-Abdi T; Shi Z
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30871131
[TBL] [Abstract][Full Text] [Related]
27. Effects of carnosine supplementation on markers for the pathophysiological development of metabolic dysfunction-associated steatotic liver disease in a diet-induced model.
Grandini NA; Costa MR; Gregolin CS; Siqueira JS; Vieira TA; Togneri Ferron AJ; Francisqueti-Ferron FV; Romualdo GR; Lúcia Dos Anjos Ferreira A; Aldini G; Corrêa CR; Moreto F
Mol Cell Endocrinol; 2024 Mar; 582():112138. PubMed ID: 38147954
[TBL] [Abstract][Full Text] [Related]
28. A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients.
Zhang X; Daniel CR; Soltero V; Vargas X; Jain S; Kanwal F; Thrift AP; Balakrishnan M
Am J Gastroenterol; 2024 Mar; 119(3):505-511. PubMed ID: 37737674
[TBL] [Abstract][Full Text] [Related]
29. The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque.
Huang Y; Wang Y; Xiao Z; Yao S; Tang Y; Zhou L; Wang Q; Xie Y; Zhang L; Zhou Y; Lu Y; Zhu W; Chen M
BMC Cardiovasc Disord; 2023 Nov; 23(1):554. PubMed ID: 37951879
[TBL] [Abstract][Full Text] [Related]
30. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community.
Dhingra R; Sullivan L; Jacques PF; Wang TJ; Fox CS; Meigs JB; D'Agostino RB; Gaziano JM; Vasan RS
Circulation; 2007 Jul; 116(5):480-8. PubMed ID: 17646581
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies.
Chan KE; Ong EYH; Chung CH; Ong CEY; Koh B; Tan DJH; Lim WH; Yong JN; Xiao J; Wong ZY; Syn N; Kaewdech A; Teng M; Wang JW; Chew N; Young DY; Know A; Siddiqui MS; Huang DQ; Tamaki N; Wong VW; Mantzoros CS; Sanyal A; Noureddin M; Ng CH; Muthiah M
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):488-498.e14. PubMed ID: 37775028
[TBL] [Abstract][Full Text] [Related]
32. Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018.
Mai Z; Chen Y; Mao H; Wang L
J Diabetes; 2024 Jun; 16(6):e13569. PubMed ID: 38751375
[TBL] [Abstract][Full Text] [Related]
33. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up.
Choe HJ; Moon JH; Kim W; Koo BK; Cho NH
Metabolism; 2024 Apr; 153():155800. PubMed ID: 38266957
[TBL] [Abstract][Full Text] [Related]
34. Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.
Son DH; Kwon YJ; Lee JH
J Nutr Health Aging; 2024 Jun; 28(6):100270. PubMed ID: 38833877
[TBL] [Abstract][Full Text] [Related]
35. Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
Song Z; Miao X; Xie X; Tang G; Deng J; Hu M; Liu S; Leng S
Lipids Health Dis; 2024 May; 23(1):141. PubMed ID: 38760825
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies.
van Son KC; Te Nijenhuis-Noort LC; Boone SC; Mook-Kanamori DO; Holleboom AG; Roos PR; Lamb HJ; Alblas G; Coenraad MJ; Rosendaal FR; de Mutsert R; Tushuizen ME
Medicine (Baltimore); 2024 Jan; 103(1):e34934. PubMed ID: 38181294
[TBL] [Abstract][Full Text] [Related]
37. Soft drink consumption and gestational diabetes risk in the SUN project.
Donazar-Ezcurra M; Lopez-Del Burgo C; Martinez-Gonzalez MA; Basterra-Gortari FJ; de Irala J; Bes-Rastrollo M
Clin Nutr; 2018 Apr; 37(2):638-645. PubMed ID: 28262323
[TBL] [Abstract][Full Text] [Related]
38. Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.
Sogabe M; Okahisa T; Kagawa M; Sei M; Ueda H; Yokoyama R; Kagemoto K; Tanaka H; Kida Y; Nakamura F; Tomonari T; Okamoto K; Kawano Y; Miyamoto H; Sato Y; Nakasono M; Takayama T
J Gastroenterol Hepatol; 2024 Jun; 39(6):1107-1114. PubMed ID: 38419514
[TBL] [Abstract][Full Text] [Related]
39. Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea.
Kwon YJ; Choi JE; Hong KW; Lee JW
J Transl Med; 2024 Jun; 22(1):591. PubMed ID: 38918799
[TBL] [Abstract][Full Text] [Related]
40. Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan.
Kim D; Perumpail BJ; Cholankeril G; Ahmed A
Eur J Nutr; 2024 Apr; 63(3):995-1001. PubMed ID: 38260997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
